Elastography generates or tracks mechanical waves as they pass through liver tissue. The measurement system evaluates wave propagation or tissue displacement, then converts that behavior into an estimate of mechanical resistance. Tissue affected by more fibrosis often produces higher stiffness values, allowing clinicians to obtain information about structural change without relying exclusively on an invasive biopsy.
These approaches use the same general physical principle but assess tissue behavior through different measurement strategies. Transient elastography and ultrasound shear-wave elastography evaluate mechanical waves using ultrasound-based techniques, whereas magnetic resonance elastography tracks wave-related tissue displacement with magnetic resonance imaging. The selected method therefore affects how wave information is acquired and interpreted in clinical evaluation.
Fibrosis is an important contributor to increased liver stiffness, but the measurement can also be influenced by inflammation, congestion, and other conditions identified in the clinical context. Consequently, a high value should not be treated as a standalone diagnosis of advanced fibrosis. Reviewing stiffness alongside laboratory results and imaging helps distinguish disease-related structural change from other influences.
The result provides an estimate that can support assessment of fibrosis and disease severity, rather than directly measuring every aspect of liver function. Higher values often correspond to greater fibrosis, but interpretation depends on the broader clinical picture and potential confounding conditions. This makes the measurement useful for risk stratification when combined with laboratory and imaging findings.
Clinicians select an appropriate elastography approach, obtain a liver stiffness measurement, and interpret the result in relation to suspected chronic liver disease. The value is then considered with laboratory tests, imaging findings, and relevant clinical conditions that may alter stiffness. This integrated workflow supports assessment of disease severity while reducing reliance on biopsy for some evaluations.
Because it can be performed noninvasively, liver stiffness measurement can support longitudinal assessment of chronic liver disease. Clinicians may compare results over time when evaluating possible disease progression or response to treatment, while still considering inflammation, congestion, and other factors that can change measurements. Serial interpretation is most informative when integrated with other clinical findings.
Liver stiffness measurement adds quantitative information about the likelihood of substantial fibrosis and the severity of chronic liver disease. Used with laboratory and imaging findings, it helps clinicians organize patients according to relative risk and determine how disease status should be evaluated over time. Its noninvasive nature also makes it a practical complement to, rather than an automatic replacement for, broader clinical assessment.